Staines, Donald R · Medical hypotheses · 2004 · DOI
This paper proposes that ME/CFS may develop when the immune system mistakenly attacks natural signaling chemicals in the body called vasoactive neuropeptides, which are crucial for nerve function, blood flow, temperature regulation, and immune balance. The author suggests this autoimmune attack could be triggered by infection, intense exercise, or occur on its own, and explains how damage to these chemicals could cause the main symptoms of ME/CFS including fatigue, muscle pain, brain fog, and chemical sensitivity.
This paper provides a unifying biological framework that could explain how a single pathological process—autoimmunity against neuropeptides—produces the diverse and seemingly disconnected symptoms of ME/CFS. If validated, this hypothesis could redirect research toward measurable immune markers and neuropeptide dysfunction, potentially opening new diagnostic and therapeutic avenues for a condition lacking clear biomarkers.
This is a theoretical hypothesis without original research data, animal models, or patient studies—it does not prove that neuropeptide autoimmunity causes ME/CFS, only that such a mechanism is biologically plausible. The paper does not establish correlation or causation in any patient population, nor does it address why neuropeptide autoimmunity would specifically trigger in some individuals after infection but not others. Technical challenges in measuring these extremely low-concentration peptides mean the hypothesis remains difficult to test with current methods.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →